Market Tracker

04/28 5:16pm ET

Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

127.78
Delayed Data
As of Apr 28
 +0.87 / +0.69%
Today’s Change
109.12
Today|||52-Week Range
157.02
+4.44%
Year-to-Date

Today’s Trading

Previous close126.91
Today’s open127.67
Day’s range125.64 - 128.74
Volume3,167,438
Average volume (3 months)2,216,722
Market cap$28.6B
Dividend yield--
Data as of 4:00pm ET, 04/28/2017

Growth & Valuation

Earnings growth (last year)+162.69%
Earnings growth (this year)+13.26%
Earnings growth (next 5 years)+26.00%
Revenue growth (last year)+21.11%
P/E ratio72.6
Price/Sales9.22
Price/Book3.27

Competitors

 Today’s
change
Today’s
% change
VRTXVertex Pharmaceutica...+0.88+0.75%
ZTSZoetis Inc-0.35-0.62%
BAXBaxter International...+0.26+0.47%
INCYIncyte Corp+0.11+0.09%
Data as of 4:14pm ET, 04/28/2017

Financials

Last reporting dateApril 27, 2017
EPS forecast (this quarter)$1.24
Annual revenue (last year)$3.0B
Annual profit (last year)$399.0M
Net profit margin13.25%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Ludwig N. Hantson
Executive Vice President-
Global Operations
Julie O'Neill
Corporate headquarters
New Haven, Connecticut

Forecasts